Quantification of intrapancreatic fat in type 2 diabetes by MRI
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Accumulation of intrapancreatic fat may be important in type 2 diabetes, but widely varying data have been reported. The standard quantification by MRI in vivo is time consuming and dependent upon a high level of experience. We aimed to develop a new method which would minimise inter-observer variation and to compare this against previously published datasets. METHODS: A technique of 'biopsying' the image to minimise inclusion of non-parenchymal tissues was developed. Additionally, thresholding was applied to exclude both pancreatic ducts and intrusions of visceral fat, with pixels of fat values of <1% or >20% being excluded. The new MR image 'biopsy' (MR-opsy) was compared to the standard method by 6 independent observers with wide experience of image analysis but no experience of pancreas imaging. The effect of the new method was examined on datasets from two studies of weight loss in type 2 diabetes. RESULTS: At low levels of intrapancreatic fat neither the result nor the inter-observer CV was changed by MR-opsy, thresholding or a combination of the methods. However, at higher levels the conventional method exhibited poor inter-observer agreement (coefficient of variation 26.9%) and the new combined method improved the CV to 4.3% (p<0.03). Using either MR-opsy alone or with thresholding, the new methods indicated a closer relationship between decrease in intrapancreatic fat and fall in blood glucose. CONCLUSION: The inter-observer variation for quantifying intrapancreatic fat was substantially improved by the new method when pancreas fat levels were moderately high. The method will improve comparability of pancreas fat measurement between research groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Adipose tissue expansion and intra organ fat accumulation are correlated with high levels of lipid inflammatory markers that cause oxidative stress in obesity and type 2 diabetes [18], and calorie restriction was reported to be associated with decrease in oxidative stress caused by lipid peroxidation [19].”
BackgroundPancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Self-citationTabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898 · cited 1×
“Type 2 diabetes never develops without substantial impairment of intrapancreatic insulin secretory capacity [1, 2].”
BackgroundZhou, Y. P., & Grill, V. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117042 · Cited by 677
Hallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529 · cited 1×
“Visceral and subcutaneous fat areas at L4-L5 were calculated from the L4-L5 proton density fat fraction map by thresholding and watershed analysis [41].”
MethodSelf-citationSteven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418 · cited 5×
“…12.2±12% 4.8±3.5% p<0.05 Chai et al. (2016) MRI 70 T2DM/30 NGT ROI = 158.46/ 154.37/ 156.47 mm2 head/body/tail 5.2±3.8% 3.5±2.0% p<0.05 Steven et al. (2016a) MRI 29 T2DM (VLCD intervention) ROI = varied size head/body/tail 5.7± 0.5% N/A N/A Steven et al. (2016b) MRI 18 T2DM/ 9…”
InfluentialSteven (2016) · doi:10.2337/dc15-0750 · Cited by 171
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance
Ferrannini, E., Nannipieri, M., Williams, K., Gonzales, C., Haffner, S. M., & Stern, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.1.160 · Cited by 153
Pinnick, K., Neville, M., Clark, A., & Fielding, B. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22445 · Cited by 55
Cited by
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Self-citationUnderstanding the mechanisms of reversal of type 2 diabetes
Taylor, R., Al-Mrabeh, A., & Sattar, N. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30076-2 · Cited by 299
Self-citationAl-Mrabeh, A., Hollingsworth, K. G., Shaw, J. A. M., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30303-x · Cited by 122
Self-citationJesuthasan, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Hollingsworth, K. G., Sattar, N., Lean, M. E. J., Taylor, R., & Al-Mrabeh, A. H. (2022) · Diabetologia · doi:10.1007/s00125-021-05583-4 · Cited by 30
Self-citation
Metadata
- Authors
- Al-Mrabeh, A., Hollingsworth, K. G., Steven, S., Tiniakos, D., & Taylor, R.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-04-03
- Volume
- 12
- Issue
- 4
- Pages
- e0174660
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2605076005
- Cited by
- 93
- References
- 10
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantification of intrapancreatic fat in type 2 diabetes by MRI. https://app.cochat.ai/papers/10.1371/journal.pone.0174660
- The paper
- Al-Mrabeh, A., Hollingsworth, K. G., Steven, S., Tiniakos, D., & Taylor, R. (2017). Quantification of intrapancreatic fat in type 2 diabetes by MRI. PLOS ONE. https://doi.org/10.1371/journal.pone.0174660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.